Otonomy to Report Fourth Quarter and Full Year 2021 Financial Results and Provide Corporate Update

Back to Jobs

SAN DIEGO , Feb. 17, 2022 (GLOBE NEWSWIRE) — Otonomy , Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced it will report financial results for the fourth quarter and full year 2021 and provide a corporate update

Apply Now